Clinical trial
A Phase Ib Study of Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
NCT03792347 is registered in ClinicalTrials.gov with Hecheng Li M.D., Ph.D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase Ib Study of Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
- Lead sponsor
- Hecheng Li M.D., Ph.D
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 21, 2019
- Completion date
- June 17, 2020
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.